Adagene to Present at Investor Conferences in June
Adagene to Present at Investor Conferences in June
SAN DIEGO and SUZHOU, China, May 22, 2024 (GLOBE NEWSWIRE) -- Adagene Inc. ("Adagene") (Nasdaq: ADAG), a company transforming the discovery and development of novel antibody-based therapies, today announced its participation in multiple investor conferences in June 2024.
中國聖地亞哥和蘇州，2024年5月22日（GLOBE NEWSWIRE）——致力於改變新型抗體療法發現和開發的公司Adagene Inc.（“Adagene”）（納斯達克股票代碼：ADAG）今天宣佈參加2024年6月的多個投資者會議。
Adagene's Chairman, Chief Executive Officer and President of R&D, Peter Luo, Ph.D., will provide a company update, including progress on the masked, anti-CTLA-4 SAFEbody ADG126. Company management will also host investor meetings.
Adagene董事長、首席執行官兼研發總裁彼得·羅博士將提供公司最新情況，包括蒙面抗CTLA-4 SafeBody ADG126 的進展情況。公司管理層還將主持投資者會議。
Jefferies Global Healthcare Conference 2024
2024 年傑富瑞全球醫療保健大會
Date: Wednesday, June 5
Time: 4:30-4:55 PM (Eastern Time)
Location: New York City
日期：6月5日星期三
時間：下午 4:30-4:55（東部時間）
地點：紐約市
Goldman Sachs 45th Annual Global Healthcare Conference
高盛第 45 屆年度全球醫療保健會議
Date: Thursday, June 13
Time: 10:00-10:35 AM (Eastern Time)
Location: Miami
日期：6月13日星期四
時間：上午 10:00-10:35（東部時間）
地點：邁阿密
HC Wainwright 2nd Annual Immune Cell Engager Virtual Conference
HC Wainwright 第二屆年度免疫細胞參與者虛擬會議
Date: Tuesday, June 25
Time: TBD for presentation
Location: Virtual
日期：6月25日星期二
時間：待演講
地點：虛擬
A live webcast of the presentations will also be accessible in the Investors section of the company's website. A webcast replay will be available for at least 30 days.
還可以在公司網站的 “投資者” 部分觀看演講的網絡直播。網絡直播重播將持續至少 30 天。